Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions

International Journal of Hematology

Volumn 88, Issue 3, 2008, Pages 331-335

  Yoshimitsu, Makoto ^a   Fujiwara, Hiroshi ^b   Ozaki, Atsuo ^a   Hamada, Heiichiro ^a   Matsushita, Kakushi ^a   Arima, Naomichi ^c   Tei, Chuwa ^c  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

DLI; Imatinib; Ph+ ALL; Relapse post allo HSCT

Indexed keywords

ANTINUCLEAR ANTIBODY; BCR ABL PROTEIN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IMATINIB; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CASE REPORT; CD3+ T LYMPHOCYTE; DONOR LYMPHOCYTE INFUSION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; GENE MUTATION; HLA MATCHING; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MONOZYGOTIC TWINS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MYELOABLATIVE CONDITIONING; PHILADELPHIA 1 CHROMOSOME; SINGLE DRUG DOSE; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADULT; CYCLOSPORINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVING DONORS; LYMPHOCYTE TRANSFUSION; MALE; PHILADELPHIA CHROMOSOME; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN KINASE INHIBITORS; PYRIMIDINES; REMISSION INDUCTION; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS;

EID: 60049101574     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0150-z     Document Type: Article

References (20)

1. AJ Barrett MM Horowitz RC Ash 1992 Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia Blood 79 3067 70
2. BJ Druker S Tamura E Buchdunger 1996 Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 2 561 6
3. OG Ottmann BJ Druker CL Sawyers 2002 A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias Blood 100 1965 71
4. B Wassmann H Pfeifer UJ Scheuring 2004 Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) treated with imatinib Blood 103 1495 8
5. BJ Druker CL Sawyers H Kantarjian 2001 Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 1038 42
6. RH Collins Jr O Shpilberg WR Drobyski 1997 Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 15 433 44
7. M Towatari M Yanada N Usui 2004 Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia Blood 104 3507 12
8. ME Gorre M Mohammed K Ellwood 2001 Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification Science 293 876 80
9. BJ Druker M Talpaz DJ Resta 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 7
10. H Kantarjian C Sawyers A Hochhaus 2002 Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia N Engl J Med 346 645 52
11. M Yanada J Takeuchi I Sugiura 2006 High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group J Clin Oncol 24 460 6
12. B Wassmann H Pfeifer M Stadler 2005 Early molecular response to posttransplantation imatinib determines outcome in MRD + Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) Blood 106 458 63
13. BN Savani R Srinivasan I Espinoza-Delgado 2005 Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib Lancet Oncol 6 809 12
14. F Michor TP Hughes Y Iwasa 2005 Dynamics of chronic myeloid leukaemia Nature 435 1267 70
15. AW Loren DL Porter 2008 Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation Bone Marrow Transplant 41 483 93
16. CI Chen HT Maecker PP Lee 2008 Development and dynamics of robust T cell responses to CML under imatinib treatment Blood 111 5342 9
17. A Takami H Okumura H Yamazaki 2005 Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation Int J Hematol 82 449 55
18. A Burchert S Wolfl M Schmidt 2003 Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia Blood 101 259 64
19. AB Dietz L Souan GJ Knutson PA Bulur MR Litzow S Vuk-Pavlovic 2004 Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo Blood 104 1094 9
20. KM Brauer D Werth K von Schwarzenberg 2007 BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells Cancer Res 67 5489 97